Activity Description
In this video, Mitchel Ibach, OD, FAAO highlights challenges and opportunities for optometrists in monitoring glaucoma progression. It provides key insights on how to select appropriate therapies for personalized glaucoma treatment, set patient expectations, and work collaboratively.
Accreditation
Sponsored by
The Fundingsland Group, LLC is a COPE-Approved Administrator.
This activity, COPE Activity Number 130238, is accredited by COPE for continuing education for optometrists. This course is approved for .25 hours of CE.
Course # 96645-GL
Activity #: 130238
COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.
Release Date: 03-31-2025
Expiration Date: 03-31-2026
Grant Support Statement
This activity is supported by unrestricted educational grants from Apellis Pharmaceuticals, Inc., LENZ Therapeutics, Orasis Pharmaceuticals,Tarsus Pharmaceuticals, Inc., Topcon Healthcare, Inc., and Viatris, Inc.
Faculty
